ABBOTT LABORATORIES : Change in Directors or Principal Officers (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers

As previously reported, Abbott has Agreements Regarding Change in Control ("Agreements") with its named executive officers.

The Agreements provide that if Abbott gives notification of extension before the Expiration Date (December 31, 2022), the Agreement's term shall continue through the second anniversary of the Expiration Date.

On October 18, 2022, Abbott notified the named executive officers that the term of the Agreements was extended through December 31, 2024.

© Edgar Online, source Glimpses